Results 251 to 260 of about 9,478,616 (387)
Phenotype and function of human T lymphocyte subsets: Consensus and issues
V. Appay +3 more
semanticscholar +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
A cross-sectional study assessing the emergency medicine knowledge of final-year interns in the Eastern Cape, South Africa. [PDF]
Ah Yui L, Taljaard L, Geraty S.
europepmc +1 more source
SOME QUESTIONS CONCERNING THE LOW-ENERGY LIMIT OF SUPERSTRING THEORIES
Hans Peter Nilles
openalex +1 more source
Beyond The Kosovo Status Question: The Limits to Europe's State-Building Efforts
Wim Carton
openalex +1 more source
The Case of a 28‐Year‐Old Woman With Medically Refractory Focal Epilepsy
ABSTRACT We present the case of a 28‐year‐old right‐handed woman with medically refractory focal epilepsy. Her seizure semiology and electroencephalography (EEG) indicated a seizure onset zone in the right central‐parietal area. However, both MRI and PET scans were unremarkable, showing no focal lesions or areas of altered metabolism.
Rishi Sharma +5 more
wiley +1 more source
How useful is ChatGPT in answering point-of-care questions in primary care? [PDF]
Prazeres F.
europepmc +1 more source
ABSTRACT Background Myasthenia gravis (MG) is a rare disorder characterized by fluctuating muscle weakness with potential life‐threatening crises. Timely interventions may be delayed by limited access to care and fragmented documentation. Our objective was to develop predictive algorithms for MG deterioration using multimodal telemedicine data ...
Maike Stein +7 more
wiley +1 more source
Opportunities, challenges and future perspectives for target trial emulation in critical care clinical research. [PDF]
Reep CAT, Wils EJ, Heunks L.
europepmc +1 more source

